RESUMEN
Immunization is one the greatest prevention tools in the skillset of the general pediatrician. Ensuring that all patients, particularly adolescents and young adults, have the opportunity and access to age-appropriate vaccines should be an integral part of pediatric practice. Equitable immunization access and allocation should be afforded to adolescents and young adults to foster the health and well-being of America's next generation. This article will focus on select inequities that create health disparities disproportionately affecting adolescents and young adults of color. We seek to highlight inequities in adolescents and young adult vaccination and explore strategies for improving equity among this unique group. [Pediatr Ann. 2023;52(3):e102-e105.].
Asunto(s)
Vacunas , Adulto Joven , Humanos , Adolescente , Niño , Vacunación , Inmunización , PediatrasRESUMEN
PURPOSE: Although both vaccines are designed to prevent human papillomavirus (HPV) infection, HPV2 and HPV4 have different indications. This study sought to determine HPV and HPV vaccine knowledge among providers and examine factors affecting HPV vaccine delivery. METHODS: An e-mail survey was sent to adolescent health care providers via listserv. RESULTS: Provider HPV vaccine knowledge level and number of providers offering vaccine to males (84%) were high. The ability of providers to correctly distinguish between the two vaccines was associated with years in practice, proportion of female patients, provider subspecialty status, and practicing in a hospital setting. CONCLUSIONS: This study demonstrates that adolescent medicine providers, in particular, are knowledgeable about HPV and HPV vaccines. They reported routinely offering HPV vaccine to male patients during the time before the recent change in recommendation for universal, routine HPV vaccination of males by the Advisory Committee on Immunization Practices.
Asunto(s)
Actitud del Personal de Salud , Conocimientos, Actitudes y Práctica en Salud , Infecciones por Papillomavirus/prevención & control , Vacunas contra Papillomavirus/administración & dosificación , Adolescente , Femenino , Humanos , Masculino , Encuestas y Cuestionarios , Estados UnidosRESUMEN
STUDY OBJECTIVE: Premenstrual dysphoric disorder (PMDD) often starts in adolescence, but there are limited data on its prevalence. The specific aims of this study were to (1) describe the prevalence of PMDD in adolescents presenting to clinics in the midwestern United States and 2 Nigerian cities, (2) identify cultural differences, and (3) screen for comorbidities. DESIGN: A cross-sectional survey was conducted among adolescents attending outpatient clinics in the 3 sites. Study participants provided demographic information and completed a modified version of the Premenstrual Symptoms Screening Tool. They also completed the modified Mini International Neuropsychiatric Interview screen for comorbid psychiatric conditions. RESULTS: Five-hundred thirty-seven patients participated in the study. The participants were between 13-21 years old (mean [SD] =16.9 [2.02] years). The overall prevalence of PMDD was 4.1% (Maiduguri, Nigeria 6.5%; Lagos, Nigeria 3.1%; and 2.9% in Akron, United States). The differences were not statistically significant (P = .167). The prevalence of moderate to severe premenstrual syndrome ranged from 12.4%-16.3% among the 3 sites, with an overall prevalence of 14.5%. There was a significantly higher prevalence of other mood disorders in Akron (19.3%) compared to the Nigerian sites (P < .001.). This difference across cultures was statistically significant. CONCLUSIONS: Premenstrual dysphoric disorder is prevalent across different cultures. It is a chronic condition that causes significant morbidity among adolescents. There is a need for simple diagnostic methods for early detection and evidence-based management guidelines.